Managing Progressive Hodgkin Lymphoma After High-Dose Therapy/Autologous Stem Cell Transplantation

In this downloadable slideset, Pier Luigi Zinzani, MD, PhD, reviews current and emerging data relevant to the treatment of patients with classical Hodgkin lymphoma and progression following stem cell transplantation.
Format: Microsoft PowerPoint (.ppt)
File Size: 580 KB
Released: December 12, 2017


This activity is supported by educational grants from
Merck & Co., Inc.
Takeda Oncology
Seattle Genetics

Related Content

Downloadable slideset with highlights from key hematologic cancers as presented at EHA 2022 Congress, from Clinical Care Options (CCO)

Stéphane de Botton, MD Jesús F. San-Miguel, MD, PhD Alessandra Tedeschi, MD Released: June 30, 2022

Experts discuss important new data from ASCO 2022 that may impact treatment for chronic lymphocytic leukemia and mantle cell lymphoma, from Clinical Care Options (CCO)

Brad S. Kahl, MD Anthony Mato, MD, MSCE Released: June 30, 2022

From Clinical Care Options (CCO), download slides reviewing the integration of CAR T-cell therapy into community care

Jesús G. Berdeja, MD Caron A. Jacobson, MD Released: June 30, 2022

Slides from Clinical Care Options (CCO) with key findings on BTK inhibitors in CLL and MCL from the 2022 ASCO, EHA, Pan Pacific, ESMO, and SOHO meetings

Released: June 27, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings